Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
BPA Levels In Bodies are Much Higher Than Previously Thought , Researchers Warn December 12, 2019 Martha Garcia Add Your CommentsThe widely used chemical bisphenol-A has previously been shown to have far-reaching side effects on human health, and a new study suggests that the way scientists typically measure exposure may provide drastic under-estimates.BPA is ubiquitous in our environment, and commonly found in many consumer products, such as plastic bottles, cash register receipts, food packaging and the lining inside of canned foods.It is a high production molecule, with approximately 9 million tons made every year, several studies have raised concerns about the side effects of BPA, with some finding that exposure even at low levels considered safe by regulatory agencies can cause serious harm to humans.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe chemical is an endocrine disruptor, meaning it can interfere with and mimic the bodyโs hormones leading to serious health effects. Research has linked BPA exposure during pregnancy to decreased infant lung function, genetic changes to a fetus, and increased miscarriage risk. Other effects include some types of cancer and even childhood obesity and diabetes.According to findings of a new report published this month in the medical journal The Lancet Diabetes & Endocrinology, researchers Washington State University and the University of California, San Francisco indicate that there is evidence that measuring methods used by federal regulators and others is inaccurate, and greatly underestimates daily human exposure to BPA.In this latest study researchers used updated measuring techniques, as opposed to an indirect method that has previously been used to calculate exposure, which involved measuring BPA metabolites in urine. However, since BPA begins to break down in the body rapidly, researchers indicate that urinary metabolites are not necessarily an accurate representation of BPA exposure.Researchers outlined and tested a new method of measuring BPA levels, and then compared both measuring methods to urine samples collected from 29 pregnant women, five non-pregnant women, and five men. The new method found BPA levels that were 19 times higher than levels detected using the old metabolite method.Study authors also found that the higher the levels of BPA in the human body, the worse the old method was at measuring them. In some cases the new method detected levels of BPA that were 44 times higher than those found using the old testing method.Since every BPA health threshold guideline has been based on the old testing method, including that of the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration, the health risks of BPA have been greatly underestimated, the researchers concluded.โImportantly, because estimates of human exposure have been based almost exclusively on data from indirect methods, these findings provide compelling evidence that human exposure to BPA is far higher than has been assumed previously,โ researchers concluded. โBecause negligible exposure levels have been a cornerstone of regulatory decisions, including the FDA conclusion that BPA poses little health risk, the present data raise urgent concerns that risks to human health have also been dramatically underestimated.โ Written by: Martha GarciaHealth & Medical Research WriterMartha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Bisphenol A, Chemicals, Endocrine Disruptors, PlasticsMore Lawsuit Stories Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials November 11, 2026 Google Gemini AI Lawsuit Alleges Chatbot Encouraged 13-Year-Old Girl to Plan Suicide November 11, 2026 Dupixent CTCL Lawsuits Can Be Directly Filed in Federal MDL November 11, 2026 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: yesterday)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026) Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: 2 days ago)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITGabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026) FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: 2 days ago)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials November 11, 2026
Google Gemini AI Lawsuit Alleges Chatbot Encouraged 13-Year-Old Girl to Plan Suicide November 11, 2026
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: yesterday)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: 2 days ago)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITGabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: 2 days ago)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)